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Abstract  
Introduction: The disparity between the increasing burden of cardiovascular disease (CVD) 
and available resources to treat it in sub-Saharan Africa necessitates preventive strategies. 
Total CVD risk assessment is a cost-effective approach to guide primary preventive therapy. 
However, in order to utilise this approach there has to be an understanding about it among 
the end-users. The objective of this study was to determine the awareness, use, and attitudes 
regarding total CVD risk assessment in clinical practice among physicians in Port Harcourt, 
Nigeria. 
Methods: a cross-sectional survey of 150 physicians in government hospitals and private 
practices in Port Harcourt city. The characteristics of ‘users’ versus ‘non-users’ of CVD risk 
assessment were compared with the Chi-Square test of significance. 
Results: 106 physicians completed the questionnaires. 74 (69.8%) reported awareness of tools 
available to assess total CVD risk. Among those aware, 87.1% agreed that CVD risk assessment 
is useful, 81% agreed it improves patient care, 74.3% agreed it leads to better decisions about 
recommending preventive therapies and 60% agreed that it increased the likelihood that they 
would recommend risk-reducing therapies to high-risk patients. However, 62.9% of these 
physicians felt it was time-wasting to use and only 21 (28.4%) actually use CVD risk 
assessment regularly in practice. The most commonly reported barrier was unfamiliarity with 
how to use risk estimation tools (52.8%). Majority who use it do so to guide preventive 
therapy. Female sex and the use of an Internet-enabled smartphone were associated with 
increased odds of being a ‘user’ of risk estimation tools (odds ratios 4.8, CI 1.4-16.9; and 5.9, CI 
1.7-20.0 respectively). 
Conclusion: Utilisation of risk assessments in clinical practice is low. A major barrier was non-
familiarity with how to use the tools. Continuous medical education and wider use of 
smartphone technology may represent health system approaches to tackling this issue. 
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Cardiovascular disease (CVD) represents the presentation of a pathologic atherosclerotic 
process that begins in childhood.1 It is a major cause of morbidity and mortality worldwide 
accounting for about a third of global mortality.2 This mortality is projected to increase to 
24 million deaths by 2030.3 In sub-Saharan African countries including Nigeria there is a 
rising prevalence of CVD.4 Cardiovascular disease is a multifactorial disease with genetic, 
and environmental influences that interact. The rapid adoption of western diets and 
increasing sedentariness of the population made worse by rural-urban migration in these 
areas contribute to the rise in CVD prevalence in low middle income countries. Although 
improved treatment modalities especially in developed regions of the world reduce 
mortality from CVD, the index presentation may be with sudden death or for those who 
survive an event, long-term disability. This is even worse in low and middle-income 
countries like Nigeria with scarce resources for the sophisticated management, which this 
disease often times, requires. Furthermore, majority of individuals with CVD are 
asymptomatic therefore, preventive measures remain mandatory.  
 
Cardiovascular disease prevention involves two major broad strategies- population level 
strategies and the high-risk strategies.5 The high-risk strategy works at the individual level 
to identify and treat those who on the basis of having a constellation of risk factors are at 
high absolute risk of developing cardiovascular events such as strokes and heart attacks.6, 7 
Treatment of individuals who are at high risk of developing CVD may have limited impact at 
the population level, but it greatly impacts the individual. This approach therefore 
necessitates the identification of such high-risk individuals. Opportunistic or systematic 
screening or increasing the level of public awareness such that people who have CVD risk 
factors can present for a risk assessment, can accomplish this.  
 
Risk estimation requires a tool that has been validated and evaluates relevant non-
modifiable and modifiable risk factors to calculate the absolute risk. There are no available 
risk estimation tools that are derived from the indigenous Nigerian population. However, 
even in developed nations with robust guidelines on risk assessment to aid CVD prevention, 
the uptake of total risk assessment remains suboptimal.8,9,10 An online cross-sectional 
survey involving 952 physicians in the United States, demonstrated that 92% reported 
awareness of tools available to calculate global risk of coronary heart disease.11 Over 80% of 
these agreed on the utility of risk estimation in improving patient care, and guiding better 
decisions about recommending preventive therapies. Even with this high level of 
awareness, only 41% admitted to using risk assessment in practice and the most commonly 
reported barrier was the time it takes to complete an assessment.  
 
This study set out to determine the awareness, use, and attitudes regarding total CVD risk 
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Study design: This was a cross-sectional study that involved the distribution of 
questionnaires to one hundred and fifty physicians in the bustling metropolitan city of Port 
Harcourt Nigeria. The questionnaire was an adaptation of one utilised in a study among 
physicians in the United States.11 It was pre-tested among a representative sample (10% of 
the sample size); questions that were unclear or not suitable in the local context were 
rephrased before it was finally distributed. For example a question on the original 
questionnaire ‘Do you see patients in the office or other ambulatory care setting?’ was 
rephrased to ‘Do you see patients in the government (BMH or UPTH) or private practice 
setting?’.  
A stratified random sampling technique was employed to select study participants. First the 
two specialist hospitals in the city (Braithwaite memorial specialist hospital and the 
university of Port Harcourt teaching hospital) were identified. Subsequently, a simple 
random sample was drawn from these two centres. Convenience sampling was applied to 
select physicians (practicing only in Port Harcourt) in private practice; physicians were 
randomly selected to participate during their annual general meeting held in Port Harcourt 
city. Physicians who work in the two government hospitals are involved in academia. Two 
research assistants who explained the purpose of the study delivered the questionnaires. 
Informed verbal consent was obtained prior to participation in this study. The 
questionnaires were collected from the physicians on the same day. Exclusion criteria 
included doctors who were non-physician specialists (i.e. surgeons, paediatricians and 
obstetric/gynaecologists) and non clinic-based medical doctors. Ethical approval was 
obtained from the Ethical Committee of the University of Port Harcourt Teaching Hospital. 
Variables included in the questionnaire (appendix 1) included participants sex, year of 
graduation from medical school, practice setting (government or private), position in the 
hospital and time spent in clinic-based practice. We obtained data regarding the awareness 
of tools available to assess CVD risk, the frequency of utility of these tools among those 
aware including type of tools used, the reasons for non-utility where appropriate and 
factors which the physicians thought represented barriers to their use. In addition, we 
sought information regarding the frequency of risk communication to patients as well as the 
utility of risk assessment in guiding the prescription of cardioprotective medication for 
primary prevention.  
Statistical analysis: The results are presented in tables and figures. Responses to each item 
were tabulated, missing responses were excluded, and differences were compared by 
respondent characteristics. Testing for significant differences was performed using Chi-
Square for categorical outcomes. Among the physicians who were aware of risk assessment 
tools, responses that indicated “Strongly Agree”, or Agree” were combined  into a category 
termed “Agree”, while, “Disagree” or “Strongly Disagree” were combined into a category 
termed “Disagree”. Physicians were classified as “users” and “non-users” based on their 
response to the question regarding the frequency with which they assess patients’ risk in 
practice. The former category comprised those who were aware of and, “occasionally”, 
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“most of the time”, or “always” assessed total CVD risk and the latter comprised those who 
were aware but “never” or “rarely” assessed total CVD risk. Characteristics of the 
respondents in each category were compared with the Chi-Square test of significance. 
Similarly physicians who indicated that they “occasionally”, “most of the time”, or “always 
or nearly always” use the risk estimation to communicate with patients and guide treatment 
recommendations were categorised as “those who use risk assessment to guide 
cardioprotective therapy”. The level of statistical significance was set at P<0.05. Statistical 
analysis was performed with Statistical Package for the Social Sciences for Mac, version 21.0 
(SPSS Inc., Chicago, IL, USA). 
Results 
Out of the 150 physicians invited to participate, forty declined and four were excluded due 
to incomplete information provided in the questionnaires. The response rate was thus 71%. 
There were 63 (59.4%) males giving a male: female ratio of 1.5:1. Majority were employed 
in the government teaching hospitals (77.4%). Cardiologists made up 16% of the 
respondents; physicians in general internal medicine specialties were 34.9% and 49.1% 
were general practitioners (GP’s). Only 32 (30.2%) reported using an Internet enabled 
smartphone when consulting patients. The only significant difference noted when sub-
specialty groups were compared was that cardiologists were more likely than general 
internists and GP’s to be employed in the government hospitals (Table 1).  
Less than one-third of the physicians surveyed correctly identified the high-risk category as 
absolute ten-year CVD risk of more than 20%, and the proportions were not significantly 
different among the specialties (23.5%, 29.7% and 28.8% of the cardiologists, general 
internal medicine physicians and GP’s respectively; p=0.797). On the other hand, 37.8% of 
physicians who reported being aware of risk assessment tools correctly identified the high-
risk category compared to only 6.3% of those who reported not being aware (p=0.001). 
Of the 106 physicians, 74 (69.8%) were aware of CVD risk assessment tools. Although more 
cardiologists were aware compared to the other specialist groups, this was not statistically 
significant (Table 1). Among those aware of risk assessment tools, 87.1% agreed/strongly 
agreed that CVD risk calculation is useful, 81% agreed/strongly agreed it improves patient 
care, 74.3% agreed/strongly agreed it leads to better decisions about recommending 
preventive therapies and 60% agreed/strongly agreed that it increased the likelihood that 
they would recommend risk-reducing therapies to high-risk patients. However, 62.9% of 
them felt it was time-wasting to use in daily practice (Table 2).  
Furthermore, among the physicians who were aware of tools used to calculate risk, only 21 
(28.4%) reported using risk assessment at least occasionally and of these, majority (63.7%) 
utilized a web-based application or an application installed on their phones. Seven (33%) of 
them utilized a paper chart; only 4.8% used a non-web based spreadsheet on a personal 
computer. Among the non-users, the most commonly reported barrier to  
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 % % % %  
Sex  M  59.4 76.5 64.9 50.0 0.110 
 F  40.6 23.5 35.1 50.0 
Practice  Government  77.4 100.0 86.5 63.5 0.002 




>75% 49.1 52.9 56.8 42.3 0.083 
51-74% 23.6 5.9 24.3 28.8 
50% 14.2 23.5 10.8 13.5 
25-49% 10.4 5.9 5.4 15.4 
<25% 2.8 11.8 2.7 0.0 
Use of smartphones 30.2 35.3 27.0 30.8 0.821 
Aware of tools to 
estimate CVD risk 
69.8 82.4 64.9 69.2 0.426 
Time since 
graduation 
<10 years 44.3 35.3 40.5 50.0 0.072 
10-20 years 32.1 58.8 32.5 23.1 
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Table 2. Percentage of the physicians who are aware of risk estimation tools that 
agree with the statements regarding CVD risk assessment according to user category 
Regarding CVD risk assessment Risk assessment user category 
User Non-user P 
% %  
I find it useful (n=61) 95.2 83.7 0.185 
It improves patient care (n=57) 95.2 75.5 0.052 
It leads to better decisions about whether or not 
to recommend cardio protective therapies (n=52) 
85.7 69.4 0.152 
It is time wasting (n=44) 38.1 73.5 0.005 
It increases the likelihood that I will recommend 
risk-reducing therapies to high-risk patients 
(n=42) 
71.4 55.1 0.201 
 
CVD risk assessment was unfamiliarity with how to use risk estimation tools (52.8% - 
Figure 1). The proportion of non-users who agreed that risk estimation was time wasting in 
clinical practice was significantly higher when compared to the users (Table 2). 
Among the 21 physicians who calculate CVD risk in clinical practice, majority were 
classified as “those who use risk assessment to guide cardioprotective therapy” as 95.2% 
indicated they use it to guide aspirin and BP lowering therapy, 90.5% use it to guide lipid 
lowering therapy and 95.2% communicate risk to their patients. Physicians who use 
internet-enabled smartphones when consulting patients were three times more likely to 
use risk assessment (57.1% vs. 42.9%; p=0.007; odds ratio 5.9 {CI 1.7-20.0}). Similarly, 
significantly more females compared to males used risk assessment in clinical practice 
(odds ratio 4.8 {CI 1.4-16.9} - Tables 3 and 4).  
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Table 3. Comparison of the sub-group of physicians who use risk estimation in 
practice  
 % P 
All (n=21) 28.4  
Sex   0.031 
Male  42.9  
Female  57.1  
Practice setting  0.930 
Government  85.7  
Private  14.2  
Specialty   0.088 
Cardiology  28.6  
General internal medicine 14.3  
General practitioners 57.1  
Time spent in clinic-based care  0.175 
>75% 61.9  
51-74% 28.6  
50% 9.5  
25-49% 0.0  
<25% 0.0  
Use of internet enabled smartphones  0.007 
Yes  57.1  
No  42.9  
Time since graduation  0.694 
<10 years 52.4  
10-20 years 38.1  




Table 4. Logistic regression of factors affecting outcome (’non-user’ vs ‘user’) 
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Sex 1.578 .637 6.134 .013 4.844 1.390 16.884 
Use of 
smartphone 
1.771 .626 8.010 .005 5.876 1.724 20.034 
Years since 
graduation 
-.409 .425 .927 .336 .664 .289 1.528 
Practice 
setting 
.004 .863 .000 .996 1.004 .185 5.450 
Specialty -.486 .408 1.416 .234 .615 .277 1.369 
Constant -3.909 1.798 4.729 .030 .020   
 
Discussion 
Absolute cardiovascular disease risk assessment is an integral part of cardiovascular 
disease prevention programs. With the current state of epidemiologic transition in many 
parts of sub-Saharan Africa including Nigeria, the need for CVD prevention cannot be over-
emphasised. Several guidelines have been published on CVD prevention and they all 
recommend the calculation of an individual’s short-term and even lifetime risk of CVD using 
different risk calculators as a means to guide preventative therapy. Several tools for 
estimating total cardiovascular risk are available and recommended by national and 
international guidelines.1, 6, 12 They are available as paper charts or online calculators with 
the latter incorporating more variables.  
 
Published data on the awareness and utility of risk assessment among physicians in Nigeria 
is lacking. In this study, while majority of the physicians surveyed were aware of tools to 
assess CVD risk, only 28.4% utilised risk assessment at least occasionally when reviewing 
patients in clinical settings. This is similar to what Shillinglaw et al found in their study 
among physicians in the United States.11 In contrast to that study where the most common 
reason for not utilizing risk assessment was time constraint, in our study it was the 
unfamiliarity with the tools available. When this is added to the finding that only about a 
third of the physicians correctly identified the high-risk category, it underscores the need 
for more focused physician education in our setting. Female gender and the use of Internet 
enabled smartphones allowed for increased use of risk calculators however the wide 
confidence intervals may be because of the relatively small sample size. Some calculators 
are available as free applications that are easily downloaded on electronic devices and are 
user friendly. Moreover the applications provide the user with information regarding the 
patients risk category making it easier for the user to make clinically relevant decisions. It is 
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noteworthy that only a third of the surveyed physicians use smartphones while consulting 
patients. This may be reflective of the lack of electronic patient records providing limited 
need for using these devices in practice. 
An important aspect of risk estimation is that it aids the clinician to determine the need to 
commence preventive drug therapy. This is particularly important when the drug in 
question has significant side effects such as bleeding with aspirin therapy. A systematic 
review on the impact of risk estimation in clinical practice found that in four randomised 
controlled trials, the estimation of risk by a clinician did not improve patient outcomes in 
terms of improvement of blood pressure or diabetes control.13 Another systematic review 
addressed this issue and the authors similarly found limited evidence that risk estimation 
positively impacted patient outcomes.14 However, early risk factor identification and 
modification may delay the progression of CVD and a study done in southern Australia 
showed that although only 40% of the general practitioners surveyed used risk assessment 
in clinical practice,15 similar to our study, they also showed that when the tools were used, 
they were used to guide clinical decision-making majority of the time. This suggests that 
increase in the uptake of risk assessment may have a significant impact on CVD prevention 
strategies.  
 
There are no established guidelines regarding whom to screen and what the ideal settings 
to carry out such screenings are. This coupled with the lack of facilities in some centres for 
assaying total cholesterol may be hindering factors. However there are non-lab based 
algorithms that can be employed.16 The over-riding take home point from this study is that 
risk assessment and CVD prevention has to be brought to the top of the healthcare agenda 
and updated local guidelines are long overdue. 
Limitations 
The non-response bias in this study may have led to over-estimation of awareness of CVD 
risk estimation tools as those physicians who did not respond may have differed 
significantly from the responders in terms of awareness of risk estimation. In addition the 
small sample size reduced the power of the study to find significant differences between 
‘users’ and ‘non-users’ of CVD risk estimation tools.  
Conclusion 
Risk estimation is a pivotal element in prevention of CVD. It allows proper treatment of 
patients based on their risk category and helps to avoid over treating those in low risk 
categories. Although several tools are in existence, their utility lies in their actual use by 
physicians. Majority of the physicians surveyed were aware of tools to calculate global CVD 
risk, but only one-fifth of them utilise risk assessments in clinical practice. A major barrier 
was unfamiliarity with how to use the tools. Among those who utilize risk assessment 
however, majority of them use it to communicate with patients and to guide primary 
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prevention therapy and the use of smartphones encouraged the utilisation of risk 
assessment. Continuous medical education and wider use of smartphone technology may 
represent health system approaches to tackling this important issue in CVD prevention. 
Recommendations 
 Larger studies are needed to document factors that hinder the uptake of risk 
estimation and implementation of existing guidelines on CVD prevention 
 Population based cohort studies are needed in sub-Saharan Africa in order to allow 
the collection of data needed to create risk estimation tools tailored to the 
population. This will aid in the preparation of CVD prevention guidelines specific to 
this population. 
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